AUS
NZ
UK
CA
USA
IND
Highlights:
- The share price of CSL Limited has gained a significant 9% in past one month on ASX.
- Though, the biotech company did not share any price-sensitive announcement today, the company managed to clock some gains.
- The benchmark ASX200 healthcare sector too closed tad higher on Monday.
Renowned ASX-listed healthcare giant, CSL Limited (ASX:CSL), has always marked its significant presence on the ASX. The stock showcased an upward march on the ASX even today.
CSL’s shares closed 0.222% higher at AU$287.990 per share on the ASX today (11 July).
Meanwhile, the S&P/ASX200 Health Care sector (INDEXASX:XHJ) ended 0.12% up at 41,766.60.
Why are CSL shares trading strong?
At times, certain companies end up trading in green territory despite any price-sensitive announcement due to the sectoral influence. CSL’s case might be one of them today. It can be clearly seen that the sectoral influence might have pushed the share price up.
The S&P/ASX200 Healthcare sector closed 0.12% at 41,766.60 on the ASX today (as of 4:39 PM AEST, 11 July).
Another reason that might have impacted the share price of CSL could be the rollout of the fourth COVID-19 vaccine in Australia.
On 7 July 2022, the Australian Technical Advisory Group on Immunisation (ATAGI) announced that it is mandatory for Australian adults to take the fourth COVID-19 vaccine due to the outbreak of a different variant of the Omicron virus.
ATAGI declared that it is mandatory for individuals aged 50 and above to take the new vaccine. Individuals aged between 30 and 49 may also take the vaccine, however, they remain less vulnerable to the disease.
About CSL Limited:
Image Source © 2022 Kalkine Media ®
An overview of CSL’s share price movement on the ASX:
The shares of CSL have performed considerably well on the ASX in last 12 months. In a year’s time, CSL’s share price has gained 3.20% on the ASX. However, on YTD basis, CSL’s share price has slid by 2.70% on the ASX (As of 4:10 PM AEST, 11 July)
